Citation Impact
Citing Papers
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Nanoparticles: Properties, applications and toxicities
2017 Standout
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective
2023 StandoutNobel
Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model
2008
Engineering precision nanoparticles for drug delivery
2020 Standout
Expanding antigen-specific regulatory networks to treat autoimmunity
2016 Nature
Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7
2010
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
2019 Standout
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
2017
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens
2015
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Virus-like particles in vaccine development
2010
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Structure of Dengue Virus
2002 Standout
Local Immunomodulation with Anti-inflammatory Cytokine-Encoding Lentivirus Enhances Functional Recovery after Spinal Cord Injury
2018
Antigen-specific immunotherapies in rheumatic diseases
2017
Delivery technologies for cancer immunotherapy
2019 Standout
Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
2018
Antigen-specific therapeutic approaches for autoimmunity
2019
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
2018 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
2008
Roots and perspectives of contemporary papillomavirus research
1996 StandoutNobel
The Future of Immunotherapy: A 20-Year Perspective
2017
Unintended effects of drug carriers: Big issues of small particles
2018
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy
2016
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses
2018
Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
2019
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Engineering nanoparticles to overcome barriers to immunotherapy
2016
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury
2023 StandoutNobel
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Human Parvovirus B19
2002 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Design and Optimization of PLGA Particles to Deliver Immunomodulatory Drugs for the Prevention of Skin Allograft Rejection
2019
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Natural and Induced Tolerogenic Dendritic Cells
2020
Monoclonal antibodies: technologies for early discovery and engineering
2017
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
2014
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Suppression of Murine Lupus by CD 4+ and CD 8+ Treg Cells Induced by T Cell–Targeted Nanoparticles Loaded With Interleukin‐2 and Transforming Growth Factor β
2018
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Virus-like particles: flexible platforms for vaccine development
2007
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Nanotechnology and its Applications in Medicine
2015
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Synthetic Nanoparticles for Vaccines and Immunotherapy
2015
Works of Zoe Hunter being referenced
Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice
2017
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-β without concomitant T cell responses
2006
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
2009
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
2012
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
2014
Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization
2016
Targeted immunomodulation using antigen‐conjugated nanoparticles
2014